Can Wegovy Affect Your Menstrual Cycle?

Weight loss and hormones: the mechanism behind cycle changes

The STEP 1 clinical trial (published in the New England Journal of Medicine) showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. That scale of loss has measurable hormonal consequences. Adipose tissue is metabolically active: it produces and stores oestrogen, and excess body fat is associated with elevated androgen levels. As fat mass falls, the hormonal balance shifts.

Sex-hormone-binding globulin (SHBG) typically rises with weight reduction, binding free androgens and oestrogens differently than before. Insulin sensitivity often improves significantly too. Both changes can ripple through the hypothalamic-pituitary-ovarian axis, the signalling chain that governs the menstrual cycle. The result can be cycles that arrive more frequently or less so, that are heavier or lighter, or that shift their timing in the early months of treatment.

This isn't unique to semaglutide. It's a recognised consequence of substantial weight loss by any means. What makes GLP-1 treatment noteworthy is the speed and degree of that loss, which can accelerate the hormonal adjustment period.

PCOS: where semaglutide may actually help cycle regularity

Polycystic ovary syndrome is characterised by insulin resistance and elevated androgens, two drivers that semaglutide addresses indirectly. A question our prescribers hear most weeks is whether Wegovy could improve PCOS symptoms, and the honest answer from current evidence is: possibly, for some women, as a downstream effect of weight change.

Reductions in insulin resistance are associated with lower androgen production by the ovaries, which in turn can restore more regular ovulation. Studies in women with PCOS and obesity have shown that meaningful weight loss (regardless of how it's achieved) can regularise cycles that were previously irregular or absent. Semaglutide's appetite-suppressing effect makes that weight loss more achievable for many.

It's worth being clear about what this doesn't mean. Semaglutide isn't licensed for PCOS or for fertility treatment. Any improvement in cycle regularity is a secondary effect of weight change, not a licensed indication. If fertility is a consideration, there are important contraception discussions to have with your prescriber before and during treatment. You can read more about how Wegovy relates to menstruation across the treatment cycle.

When irregularity is the problem, not the solution

Cycle changes aren't always welcome. Some women find their previously regular cycle becomes less predictable in the early weeks of treatment, particularly if weight loss is rapid. Caloric restriction itself (which the medicine facilitates) can temporarily suppress ovulation in the same way very low-calorie diets do. Nausea and vomiting, which are common in the dose-escalation phase, may compound general physical disruption. Our page on nausea and vomiting with Wegovy has detail on managing that particular side effect.

The NHS semaglutide medicines page lists the recognised side effects of the medicine; changes to the menstrual cycle don't appear there as a direct drug effect. If your cycle changes significantly (very heavy bleeding, periods stopping entirely, or any change that worries you) that's a conversation for your GP or prescriber, not something to wait out. Some cycle changes have causes entirely unrelated to the medicine.

Contraception is also a practical consideration. Weight loss can improve fertility in women who previously had irregular or absent ovulation. Assuming the medicine acts as contraception is not safe. If you're on the oral contraceptive pill and start Wegovy, your contraception should remain reliable, though the main drug-interaction concern around oral contraceptive absorption applies specifically to tirzepatide (Mounjaro) rather than semaglutide; discuss your individual situation with a prescriber. For questions about the cost of treatment, our Wegovy pricing page covers what private treatment typically involves.

What to do if your cycle changes on Wegovy

Most cycle changes in the first few months of treatment settle as the body adjusts to a new weight set-point. Tracking your cycle during treatment is practical and makes any pattern clearer. If irregularity persists beyond three months, or if it's accompanied by other symptoms (pelvic pain, very heavy flow, or anything that feels out of the ordinary) see your GP. There are other explanations worth ruling out, including thyroid changes, which can themselves be affected by significant weight loss.

You can also explore how Wegovy may interfere with the menstrual cycle in more detail, or look at the semaglutide and cycle changes page for further reading. Semaglutide has other physiological effects worth knowing about too, eye changes are one less-discussed area covered separately. If you're considering treatment or already taking it and have questions, our free consultation connects you with a GPhC-registered prescriber who can review your specific circumstances. Speak to our prescribers, it's what they're there for.